Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Indian pharma firm Orchid Chemicals & Pharmaceuticals has received closure notice for violating good manufacturing practices (GMP) compliance in connection with the disposal of solid waste at Cephalosporin API manufacturing facility located in Alathur (Chennai).
Subscribe to our email newsletter
Cephalosporin API manufacturing plant manufactures a range of oral and sterile Cephalosporin APIs and caters to the developed markets like US, Europe and Japan.
The closure notice has been issued by the Tamil Nadu Pollution Control Board (TNPCB).
Last month, the company has received the US Food and Drug Administration (FDA) approval for following inspection.
In connection with the receiving of the closure notice, the company has assured the regulatory authority to resolve the issues immediately.